What must be maintained when transferring Schedule III-V controlled substances?

When transferring Schedule III-V controlled substances, it is essential to maintain written records of the transaction. This requirement is in line with the Drug Enforcement Administration (DEA) regulations, which mandate that any transfers of controlled substances between registrants must be documented to ensure accountability and traceability in the handling of these substances.

Having written records allows for the monitoring of controlled substances and helps prevent diversion or misuse. The documentation should include details such as the names and addresses of both the sender and receiver of the substances, the date of the transfer, and the type and quantity of substances transferred.

Maintaining these records is crucial not only for compliance with the law but also for maintaining an accurate inventory and for auditing purposes. This written documentation serves as a safeguard to verify that all transactions involving controlled substances are legitimate and appropriately handled according to regulatory requirements. Without proper documentation, it would be challenging to track the movement of these substances, potentially leading to legal consequences and issues related to public safety and healthcare management.